EverBlu Capital is an Australian based boutique corporate advisory firm with over 100 years combined corporate advisory experience, knowledge and relationships.
"Acting as the bridge between companies and investors looking for growth opportunities"
EVERBLU CAPITAL
What Differentiates Us
Expertise
Integrity
People
Results Driven
The @EverBluCapital AM Report provides all-inclusive coverage on 430+ ASX listed companies & sectors, the latest market developments and company news. Written by our Research Team led by award winning analyst, Russell Wright. #Research #Markets
SIGN UP: https://t.co/UKXyiCRqqz
The @EverBluCapital Research Team initiates coverage on @CannPalAT. CPAT-01 is a drug at the forefront of a significant market opportunity worth more than US $1B p.a. #MedicalCannibis #Research #ASX #AnimalHealth
REPORT: https://t.co/suG1E6VQwe
$CPH have signed a commercial agreement with Pharmacare Europe for the marketing + distribution of cannaQIX & other products in the UK. Pharmacare have over 10,000 points of sales in Europe alone #MedicalCannabis #CBD #UK #distribution @CresoPharma
MORE: https://t.co/aoACNCDPXI
Latest News & Updates
Angel Seafood IPO Opens

Creso Pharma (CPH.ASX) November News

Elysium Resources (EYM.ASX) Acquisition News

Roots
